53 Future Directions and Unanswered Questions Despite recent evidence from clinical trials, key questions remain about the optimal use of GLP-1RAs for HF
BMI calculators can help patients estimate eligibility, track progress, and understand weight categories, but they cannot determine whether a medication is medically appropriate
Patients should never attempt to use questionable medication
Ultimately, the choice between tirzepatide vs semaglutide should be a collaborative decision made between the patient and their healthcare provider, considering all these factors
Active post-market studies are required for some PMA devices but are product-specific, not universally mandated by device class
Every person is different, but the most effective GLP-1 medications can lower the A1c by 12%